Skip to main content
Published locations for Fremanezumab switch may benefit migraine patients who are not responding to anti-CGRP mAb
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Fremanezumab switch may benefit migraine patients who are not responding to anti-CGRP mAb
User login
Username
Password
Reset your password
/content/fremanezumab-switch-may-benefit-migraine-patients-who-are-not-responding-anti-cgrp-mab
/migraine-icymi/article/263743/headache-migraine/fremanezumab-switch-may-benefit-migraine-patients